共 50 条
- [31] Hematopoietic cell transplantation (HCT) in older patients with acute myeloid leukemia (AML)JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Bhatt, Vijaya RajChen, BaojiangLee, Stephanie
- [32] Poor Treatment Outcomes of Young (<60 Years) African American Patients (Pts) Diagnosed with Acute Myeloid Leukemia (AML) (Alliance)BLOOD, 2020, 136Bhatnagar, BhavanaZhao, QiuhongFisher, James L.Kohlschmidt, JessicaMrozek, KrzysztofNicolet, DeedraOrwick, ShelleyBlachly, James S.Mims, Alice S.Walker, Christopher J.Carroll, Andrew J.Powell, Bayard L.Kolitz, Jonathan E.Paskett, Electra D.Bloomfield, Clara D.Stone, Richard M.Byrd, John C.De la Chapelle, AlbertGarzon, RamiroEisfeld, Ann-Kathrin
- [33] Characteristics and Outcomes of Older Patients With Secondary Acute Myeloid Leukemia According to Treatment ApproachCANCER, 2017, 123 (16) : 3050 - 3060Boddu, Prajwal ChaitanyaKantarjian, Hagop M.Ravandi, FarhadGarcia-Manero, GuillermoVerstovsek, SrdanJabbour, Elias J.Takahashi, KoichiBhalla, KapilKonopleva, MarinaDiNardo, Courtney D.Ohanian, MaroPemmaraju, NaveenJain, NitinPierce, SherryWierda, William G.Cortes, Jorge E.Kadia, Tapan M.
- [34] Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or olderBLOOD, 2006, 108 (01) : 45 - 51Faderl, SVerstovsek, SCortes, JRavandi, FBeran, MGarcia-Manero, GFerrajoli, AEstrov, ZO'Brien, SKoller, CGiles, FJWierda, WKwari, MKantarjian, HM
- [35] Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry StudyBLOOD, 2023, 142Grinblatt, David L.Roboz, Gail J.Pollyea, Daniel A.Sekeres, Mikkael A.Scott, Bart L.Seiter, KarenZeidan, Amer M.Patel, Jay L.Garcia-Manero, GuillermoKomrokji, Rami S.Savona, Michael R.Degutis, Irene S.Kiselev, PavelYu, EdwardHeydendael, WillemQiu, YingVergara, SaraMcBride, AliErba, Harry P.
- [36] Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of ageLEUKEMIA RESEARCH, 2013, 37 (11) : 1468 - 1471Vigil, Carlos E.Tan, WeiDeeb, GeorgeSait, Sheila N.Block, Annemarie W.Starostik, PetrGriffiths, Elizabeth A.Thompson, James E.Greene, Jessica D.Ford, Laurie A.Wang, Eunice S.Wetzler, Meir
- [37] Personalized Drug Combinations for the Treatment of Acute Myeloid Leukemia (AML) PatientsBLOOD, 2014, 124 (21)Kang, YunyiTran, TrishZhang, LindaBall, Edward D.Piermarocchi, CarloPaternostro, Giovanni
- [38] Treatment outcome of acute myeloid leukemia (AML) in HIV plus patientsJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Dy, Irene AngPatchett, MatthewMcDonald, AliciaWiernik, Peter H.
- [39] Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA studyANNALS OF HEMATOLOGY, 2025, 104 (01) : 369 - 381Sossa-Melo, ClaudiaAbello-Polo, VirginiaSalazar, Luis A.Pena, Angela M.Luna-Gonzalez, MariaCuervo-Lozada, DianaQuintero-Vega, Guillermo E.Daza, JorgeOmana-Orduz, Olga PaolaMantilla, WilliamPerdomo, IvanGalvez, KennyDiaz-Correa, Laura MariaGuerrero-Burbano, Paola AndreaHerrera, Juan ManuelIdrobo, HenryGaviria, L. M.Correa-Correa, Mario ErnestoLobaton, JoseBermudez, Carlos DanielPedraza-Morales, Julian EduardoSerrano-Casas, Juan CarlosJaramillo, FranciscoGomez, RigobertoRosales, CarmenSolano, Maria HelenaVaron, CarlosRodriguez-Veiga, RebecaMartinez-Cuadron, DavidMontesinos, Pau
- [40] Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trialHAEMATOLOGICA, 2022, 107 (07) : 1518 - 1527Russell, Nigel H.Hills, Robert K.Thomas, AbinThomas, IanKjeldsen, LarsDennis, MikeCraddock, CharlesFreeman, SylvieClark, Richard E.Burnett, Alan K.